Fisher Asset Management LLC increased its position in CVS Health Corporation (NYSE:CVS) by 2.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 132,741 shares of the pharmacy operator’s stock after buying an additional 2,958 shares during the period. Fisher Asset Management LLC’s holdings in CVS Health Corporation were worth $11,813,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Acrospire Investment Management LLC increased its position in shares of CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 900 shares during the last quarter. Springbok Capital Management LLC increased its position in shares of CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares during the last quarter. Pinkerton Retirement Specialists LLC increased its position in shares of CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock worth $110,000 after buying an additional 1,112 shares during the last quarter. MU Investments Co. Ltd. increased its position in shares of CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock worth $109,000 after buying an additional 440 shares during the last quarter. Finally, D Orazio & Associates Inc. increased its position in shares of CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 80.44% of the company’s stock.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Shares of CVS Health Corporation (NYSE:CVS) traded up 1.32% during mid-day trading on Tuesday, hitting $75.77. The company had a trading volume of 4,754,514 shares. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $106.67. The stock has a market cap of $80.80 billion, a price-to-earnings ratio of 16.24 and a beta of 0.88. The stock’s 50-day moving average is $81.47 and its 200-day moving average is $91.44.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.07. The business had revenue of $44.60 billion for the quarter, compared to analyst estimates of $45.29 billion. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The business’s quarterly revenue was up 15.5% on a year-over-year basis. During the same period last year, the company posted $1.28 EPS. Equities analysts forecast that CVS Health Corporation will post $5.81 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th were given a $0.425 dividend. This represents a $1.70 annualized dividend and a yield of 2.28%. The ex-dividend date was Thursday, October 20th. CVS Health Corporation’s dividend payout ratio (DPR) is presently 36.40%.

TRADEMARK VIOLATION NOTICE: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of US and international trademark and copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/29/fisher-asset-management-llc-has-11813000-stake-in-cvs-health-corporation-cvs.html.

CVS has been the topic of a number of research analyst reports. Mizuho restated a “buy” rating and issued a $111.00 target price on shares of CVS Health Corporation in a research report on Friday, September 30th. Credit Suisse Group AG restated a “buy” rating and issued a $115.00 target price on shares of CVS Health Corporation in a research report on Tuesday, September 20th. Argus restated a “buy” rating and issued a $120.00 target price on shares of CVS Health Corporation in a research report on Thursday, August 4th. Leerink Swann restated a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Finally, Vetr upgraded CVS Health Corporation from a “hold” rating to a “buy” rating and set a $94.49 target price on the stock in a research report on Monday, October 10th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. CVS Health Corporation presently has an average rating of “Buy” and a consensus price target of $106.24.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.